Instylla, Inc., a developer of solutions for peripheral vascular embolotherapy, announced the FDA 510(k) clearance of the ...

Bentley InnoMed GmbH announced the market launch of its BeFlow iliac covered stent system, which will be commercially available ...

Imperative Care, Inc. announced that it has received FDA 510(k) clearance of the company’s Zoom system. The comprehensive ...

Gore & Associates recently announced the first commercial use of the company’s Excluder conformable abdominal aortic ...

Artivion, Inc. announced the presentation of clinical data from the PERSEVERE United States investigational device exemption (I ...

Aptyx, a Tempe, Arizona–based developer and manufacturer of complex components and devices for the life sciences, announc ...

Venova Medical recently announced the enrollment of the first patients in the company’s VENOS-2 early feasibility study o ...

Front Line Medical Technologies announced the launch in the United Kingdom of its CE Mark-approved COBRA-OS—Control of Bl ...

Concept Medical Inc., announced the enrollment of the first patient in the pivotal MAGICAL BTK randomized controlled trial, whi ...

NextBioMedical Co., Ltd., which is based in South Korea, announced that it has received investigational device exemption (IDE) ...

Concept Medical Inc. announced the completion of patient enrollment in the SirPAD trial of the company’s MagicTouch percu ...

Alan Lumsden, MD Walter W. Fondren III Presidential Distinguished Chair, DeBakey Heart & Vascular Center Chair, Department of ...